Back to Top
Nelistotug Biosimilar - Research Grade
$710.00 - $6,900.00
Nelistotug Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
CD96ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P40200
Shipping Conditions
Blue ice
Background
CD96 is an immunoglobulin-superfamily receptor on T and NK cells that competes within the TIGIT/CD226 axis to regulate cytotoxic immune responses, a fast-growing area of checkpoint research. This unconjugated, non-therapeutic analog of nelistotug is a recombinant human IgG1 kappa antibody directed at CD96 and supplied for research use only (RUO). It is produced in scalable milligram (mg) to gram (g) quantities for heavy-usage and high-throughput laboratories and purified to low endotoxin for in vivo applications. Researchers apply it as a checkpoint control and reagent in immune functional assays, in vitro screening, and preclinical immuno-oncology models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
















